Publications

Detailed Information

CK20 Expression Enhances the Invasiveness of Tamoxifen-resistant MCF-7 Cells

DC Field Value Language
dc.contributor.authorMin, Yun Sook-
dc.contributor.authorYi, Eun Hee-
dc.contributor.authorLee, Jin-Ku-
dc.contributor.authorChoi, Ji Won-
dc.contributor.authorSim, Ji Hyun-
dc.contributor.authorKang, Jae-Seung-
dc.contributor.authorKim, Yong-Nyun-
dc.contributor.authorJuhnn, Yong-Sung-
dc.contributor.authorKim, Hang-Rae-
dc.contributor.authorYe, Sang-Kyu-
dc.date.accessioned2023-04-26T05:07:45Z-
dc.date.available2023-04-26T05:07:45Z-
dc.date.created2021-01-21-
dc.date.created2021-01-21-
dc.date.created2021-01-21-
dc.date.created2021-01-21-
dc.date.issued2012-04-
dc.identifier.citationAnticancer Research, Vol.32 No.4, pp.1221-1228-
dc.identifier.issn0250-7005-
dc.identifier.urihttps://hdl.handle.net/10371/191566-
dc.description.abstractCytokeratin 20 (CK20) is an intermediate filament that is known to be a prognostic marker in several types of cancer. However, little is known about CK20 expression and tumor metastasis in tamoxifen-resistant MCF-7 (TRM-7) breast cancer cells. TRM-7 cells overexpress CK20, resulting in enhanced invasiveness in vitro. CK20 silencing reduced the invasiveness of TRM-7 cells. Moreover, CK20 expression in MCF-7 cells was regulated by peroxisome proliferator-activated receptor gamma (PPAR gamma). Our findings suggest that PPAR gamma-dependent CK20 expression enhances the metastatic potential of MCF-7 breast cancer cells and may be a potential therapeutic target in tamoxifen-resistant breast cancer.-
dc.language영어-
dc.publisherInternational Institute of Anticancer Research-
dc.titleCK20 Expression Enhances the Invasiveness of Tamoxifen-resistant MCF-7 Cells-
dc.typeArticle-
dc.citation.journaltitleAnticancer Research-
dc.identifier.wosid000302492600012-
dc.identifier.scopusid2-s2.0-84859996800-
dc.citation.endpage1228-
dc.citation.number4-
dc.citation.startpage1221-
dc.citation.volume32-
dc.description.isOpenAccessN-
dc.contributor.affiliatedAuthorLee, Jin-Ku-
dc.contributor.affiliatedAuthorKang, Jae-Seung-
dc.contributor.affiliatedAuthorJuhnn, Yong-Sung-
dc.contributor.affiliatedAuthorKim, Hang-Rae-
dc.contributor.affiliatedAuthorYe, Sang-Kyu-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.subject.keywordPlusBREAST-CANCER CELLS-
dc.subject.keywordPlusACTIVATED RECEPTOR-GAMMA-
dc.subject.keywordPlusPOLYMERASE CHAIN-REACTION-
dc.subject.keywordPlusCYTOKERATIN 20 EXPRESSION-
dc.subject.keywordPlusINTERMEDIATE-FILAMENTS-
dc.subject.keywordPlusCOLORECTAL-CANCER-
dc.subject.keywordPlusUROTHELIAL CELLS-
dc.subject.keywordPlusMARKER-
dc.subject.keywordPlusGROWTH-
dc.subject.keywordPlusDIFFERENTIATION-
dc.subject.keywordAuthorTamoxifen-resistant breast cancer cells-
dc.subject.keywordAuthorcytokeratin 20-
dc.subject.keywordAuthortumor invasiveness-
dc.subject.keywordAuthorperoxisome proliferator-activated receptor gamma (PPAR gamma)-
dc.subject.keywordAuthorMCF-7-
dc.subject.keywordAuthorTRM-7 cells-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area 3D drug screening, Cancer Organoid, Precision Oncologuy

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share